Employee incentives through the 10th Series of Stock Acquisition Rights
First written in FY2021. 2 of 4 entries say "Advanced", first in FY2022-Q2. Latest entry: FY2023.
The whole theme swung hardest in 2023: 1 of 11 companies on the "Worse" side.
2 other companies' latest entry also says "Achieved".
- FY2023AchievedAnnual report
「If gross profit for the fiscal year ended September 2023 exceeds ¥5.600 billion: exercisable percentage 100%」
Gross profit for the fiscal year ended September 2023 was ¥6,142.399 million, exceeding the exercise condition of more than ¥5.600 billion for the 12th Series of Stock Acquisition Rights. The same result also exceeded the 14th Series condition of more than ¥5.900 billion. - FY2022AdvancedAnnual report
「13th Series of Stock Acquisition Rights (approved by the Board of Directors on 24 June 2022) Categories and number of eligible grantees Employees: 34 Directors of subsidiaries: 1」
The Company granted 49,400 shares under the 13th Series of Stock Acquisition Rights to 34 employees and 1 subsidiary director, and 144,000 shares under the 14th Series to 7 directors and 5 employees. - FY2022-Q2AdvancedAnnual report
「12th Series of Stock Acquisition Rights (approved by the Board of Directors on 24 December 2021) Categories and number of eligible grantees Directors: 9 Employees: 4 Number of stock acquisition rights (units)* 913 (Note 1) Class, details and number of shares underlying the stock acquisition rights (shares)* Common shares: 91,300 (Note 1)」
The Company disclosed a scheme granting 31,500 shares under the 11th Series of Stock Acquisition Rights to 2 directors and 7 employees, and 91,300 shares under the 12th Series to 9 directors and 4 employees. The 12th Series carries staged exercise conditions based on gross profit. - FY2021First statedAnnual report
「Categories and number of eligible grantees Employees: 25 Number of stock acquisition rights (units)* 203 [174] Class, details and number of shares underlying the stock acquisition rights (shares)* Common shares: 20,300 [17,400] Exercise period for the stock acquisition rights 1 October 2021–5 September 2031」
The Company granted the 10th Series of Stock Acquisition Rights approved on 20 August 2021 to 25 employees and introduced an incentive scheme under which some rights could be exercised from 1 October 2021 and all rights could be exercised from 1 October 2023 onward.